Bausch + Lomb BLCO Vision Care — Selling, general and administrative (Note 4)

Other segment segments

Similar metrics at other companies

COOCooperVision — Selling, general and administrative expense

$252.2M+6.5%

CHE

CHESegment Vitas — Other Selling General And Administrative Expense

$8.87M-1.5%

CHE

CHESegment Vitas — Selling General And Administrative Expense

$26.11M-1.6%

BSXCardiovascular — Selling, general and administrative expenses

$959M+9.9%

BDXConnected Care — Selling and administrative expense

$190M+18.0%

OSISOptoelectronics And Manufacturing Division — Selling General And Administrative Expense

$7.88M-0.7%

Questions, answered.

What is Bausch + Lomb's vision care — selling, general and administrative (note 4)?

Bausch + Lomb (BLCO) reported vision care — selling, general and administrative (note 4) of $228M in Q1 2026.

How has Bausch + Lomb's vision care — selling, general and administrative (note 4) changed year-over-year?

Bausch + Lomb's vision care — selling, general and administrative (note 4) increased by 3.2% year-over-year, from $221M to $228M.

What is the long-term trend for Bausch + Lomb's vision care — selling, general and administrative (note 4)?

Over 3 years (2022 to 2025), Bausch + Lomb's vision care — selling, general and administrative (note 4) has grown at a 5.2% compound annual growth rate (CAGR), from $784M to $912M.

What does vision care — selling, general and administrative (note 4) mean?

Includes all operating expenses related to the marketing, sales, and administrative support functions of the Vision Care segment. This metric reflects the overhead required to maintain the segment's market presence and distribution network. Investors monitor this to evaluate the efficiency of the segment's cost structure relative to its revenue generation.